Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02481713 · ClinicalTrials.gov registry record · NA

Improving Adherence to Cognitive Rehabilitation

A NA study of Psychosis, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
114
Enrollment target
1
Study location

NCT02481713: Completed NA study of Psychosis, sponsored by VA Office of Research and Development.

NCT02481713 is a NA study of Psychosis that has completed, run by VA Office of Research and Development. The registered enrollment target is 114 participants, below the 176-participant average among 35 other Psychosis trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02481713, a NA study of Psychosis, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
114 participants
Enrollment target
1
Study location

Study Summary

Purpose of study is to evaluate impact of brief motivational interviewing vs. feedback on learning styles in improving attendance to cognitive training

Primary Outcome

number of cognitive training sessions attended

Conditions Studied

Interventions

  • BEHAVIORAL motivational interviewing
  • BEHAVIORAL learning style interviews

Study Locations (1)

Connecticut

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2015-12-01
Est. Completion 2020-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02481713 record still lists

NCT02481713 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 176-participant average among 35 other Psychosis trials with a reported enrollment target (35% lower).

The record links to 1 condition, with Psychosis appearing as the primary indexed condition, and to 2 interventions - of which motivational interviewing is the first listed.

NCT02481713 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT02481713 about?

NCT02481713 is a clinical study titled "Improving Adherence to Cognitive Rehabilitation". Purpose of study is to evaluate impact of brief motivational interviewing vs. feedback on learning styles in improving attendance to cognitive training

What is the current status of trial NCT02481713?

This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2015-12-01. Estimated completion is 2020-09-30.

What conditions does trial NCT02481713 study?

This clinical trial studies the following conditions: Psychosis.

What interventions are being tested in trial NCT02481713?

The interventions under investigation include: motivational interviewing (BEHAVIORAL), learning style interviews (BEHAVIORAL).

Who is sponsoring clinical trial NCT02481713?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02481713 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02481713's enrollment target sits among peer trials

114 12th of 35 higher than 24 of 35 other Psychosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04522791 · 114 participants · Phase 2

    Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)

  • NCT04875052 · 114 participants · NA

    Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury

  • NCT05100342 · 114 participants

    Prospective Validation of a Points Score System Predicting 30-day Survival

  • NCT05224089 · 114 participants · Phase 4

    Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02481713, the US trial registry maintained by the National Library of Medicine. NCT02481713 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.